133591 F0233 HICT

We support pharmaceutical, medical device and medical app companies in the development of pricing and reimbursement files for Belgium.


  • Feasibility analysis on pricing and reimbursement of a product in Belgium
  • Tailor-made advice on the price and reimbursement strategy of a product
  • Development, submission and follow-up of price and reimbursement dossiers

Hict has extensive experience with health economics for Belgian reimbursement submissions.

  • Approx. 100 HEMAR projects, of which a majority of projects was to support reimbursement submissions
  • More than 90% of the submitted files have been reimbursed. We have also been applying health economics to support the broader market access challenges of our customers
HEMA Rgraph2

Health Economic experience in many disease area's

  • Extensive number of reimbursement files in oncology and hematology: AML, aBCC , kidney cancer, melanoma, NSCLC, breast cancer, cervix & ovarian cancer, DLBCL, PaLL, HL, MCL, CLL/CML , HCC, soft tissue sarcoma
  • Other therapeutic areas: COPD, neurology (migraine, Parkinson), psychiatric (MDD, schizophrenia, alcohol dependence), uveitis, cardiology, HIV, dermatology, NAFL/NASH, etc.

The collaboration with Hict was extremely insightful as they built bridges between what the RIZIV wants to see in a reimbursement file and what we as a company want to realise for our patients.


Inspiring cases

Interested in our expertise on Reimbursement?

Contact us now to optimise your business

Get in touch
Team test8